Henlius Sees Revenues Soar In 2022, Q1 2023, As New Plant Bears Fruit
Chinese Biotech Offers Trastuzumab In EU, Five Biosimilars In The Clinic
Chinese player Shanghai Henlius Biotech has published unaudited financial results for the first three months of 2023, in the wake of its 2022 annual report.
